Taysha Gene Therapies

TSHA · NASDAQ

$4.11+$0.17 (+4.31%)TodayMarket closed ·
Prev close $3.94

Who owns TSHA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 56.2% of TSHA’s shares.

  • Manning (Paul B.)8.0%
  • Avoro Capital Advisors LLC7.5%
  • RA Capital Management, LP7.4%
  • Vestal Point Capital, LP6.1%
  • Next 6 largest institutions27.3%
  • All other shareholders43.8%
Top institutional holders of TSHA
HolderShares% of shares
Manning (Paul B.)25.60M8.01%
Avoro Capital Advisors LLC23.89M7.47%
RA Capital Management, LP23.56M7.37%
Vestal Point Capital, LP19.41M6.07%
BlackRock Institutional Trust Company, N.A.18.20M5.69%
Morgan Stanley & Co. LLC16.07M5.02%
Goldman Sachs & Co. LLC13.58M4.25%
RTW Investments L.P.13.56M4.24%
Fidelity Management & Research Company LLC13.34M4.17%
Vanguard Capital Management, LLC12.48M3.90%

Largest mutual fund holders

Top mutual fund holders of TSHA
HolderShares% of shares
Vanguard Total Stock Market Index Fund9.18M2.87%
iShares Russell 2000 ETF6.22M1.94%
State Street SPDR S&P Biotech ETF5.87M1.84%
Polar Capital Biotechnology Fund4.85M1.52%
Fidelity Growth Company Fund4.17M1.30%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.25M (1 trade) of TSHA on the open market, with no buys.

Latest TSHA insider transactions
InsiderTypeSharesValue
Nagendran SukumarSale200.00K$1.25M
Long Alison SAward42.67K—
Long Alison SAward21.34K—
Sepp-Lorenzino LauraAward42.67K—
Sepp-Lorenzino LauraAward21.34K—
Stalfort John A IIIAward42.67K—
Stalfort John A IIIAward21.34K—
Donenberg Phillip B.Award42.67K—
Donenberg Phillip B.Award21.34K—

Short interest

Settled Sep 30, 2026

Shares short
55.02M
Days to cover
11.15
% of shares outstanding
17.21%
Average daily volume
4.93M
Change since last report
+7.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.